Harmony Biosciences (HRMY) Tops Q4 EPS by 1c

Harmony Biosciences (NASDAQ: HRMY) reported Q4 EPS of $0.73, $0.01 better than the analyst estimate of $0.72. Revenue for the quarter came in at $168.4 million versus the consensus estimate of $169.65 million.

For earnings history and earnings-related data on Harmony Biosciences (HRMY) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Worried the AI trade has gone too far? Evercore likes these 4 stocks
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target